Skip to content
OpenCapital
Get started

Cellectar Biosciences CLRB Q1 2026 Annual earnings

Reported May 14, 2026 · Before market open

EPS-$1.33Beat by $0.55
Revenue estimate$8.0M
EPS estimate-$1.89

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$12.0M
EPS estimate-$0.55

Versus estimates

Diluted EPS

Q1 2026-$1.33Beat by $0.55
Q4 2025-$0.53Beat by $0.66Q3 2025-$1.41Beat by $0.50Q2 2025-$3.39Beat by $0.21Q1 2025-$3.90Beat by $1.21Q4 2024-$0.01Beat by $0.37

Ask the moment Cellectar Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cellectar Biosciences report Q1 2026 earnings?
Cellectar Biosciences (CLRB) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Cellectar Biosciences's Q1 2026 revenue and EPS?
Cellectar Biosciences reported eps of $-1.33 for Q1 2026.
Did Cellectar Biosciences beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.89 by $0.55.
How did Cellectar Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 65.9% from $-3.90.
Where can I find Cellectar Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-060693) and the 10-K/A periodic report (0001104659-26-053090) directly on SEC EDGAR. The filing index links above go to sec.gov.